VR

Venkata Reddy Massireddigari

Active Director Director DIN 00137805
DIN 00137805 First appointment Jun 2004 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Reddy Massireddigari

Data last updated:

Venkata Reddy Massireddigari is a Director at Genomik Design Pharmaceuticals Private Limited (since 2004). The company operates in Chemicals.

DIN 00137805
Primary Designation Director
Industry Chemicals
First Appointment 02 Jun 2004
Oldest Company Age 23 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jun 20042003Active

Board colleagues of Venkata Reddy Massireddigari

Directorship timeline

Open interactive timeline →
Genomik Design Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Venkata Reddy Massireddigari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Reddy Massireddigari

Venkata Reddy Massireddigari currently holds 1 directorship: Genomik Design Pharmaceuticals Private Limited (Director, since 02 Jun 2004).

Venkata Reddy Massireddigari was first appointed on 02 Jun 2004 as Director at Genomik Design Pharmaceuticals Private Limited.

The current boards of Venkata Reddy Massireddigari's companies include Enkemi Reddy Mutyala (Genomik Design Pharmaceuticals Private Limited), Venkata Reddy Boilla (Genomik Design Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available